Navigating the dealmaking landscape in 2024 and beyond
Moderator:
Martina Molsbergen - CEO, C14 Consulting Group, LLC
Panelists:
Roel Bulthuis - Managing Partner, Syncona
Lubor Gaal - CFO, Circio AB
Philippe Lopes-Fernandes - CBO and Executive VP, IPSEN
Bernd Nosse - Global Head BD&L Technologies and Research Beyond Borders, Boehringer Ingelheim
This session dives into the ever-evolving landscape of dealmaking and M&A and unravels the forces reshaping the industry's dynamics. Panelists share real-world case studies and expert insights on strategies for forging strategic alliances, securing partnerships and driving innovation, to address the healthcare challenges of the future. Whether you're a pharmaceutical executive, investor, or innovator, this session navigates the intricacies of dealmaking and provides guidance for success, in 2024 and beyond. Be ready to put best practice into action at BIO-Europe Spring 2025.
